Moreover, these exosomes with miR-122 acted in vivo in mice with CCl4-induced liver fibrosis, and reduced the expression of TGF-β1 and α-SMA, and suppressed the serum levels of HA, P-III-P, ALT, AST and liver hydroxyproline content. The gene discussed is ACTA1; the disease is Hepatic fibrosis.